/

Other

/

Simcere Zaiming

Simcere Zaiming

Simcere Zaiming

Verified Nov 2026

Other

·

China flag

Nanjing, Jiangsu

·

Since 2023

Simcere Zaiming is an oncology-focused biopharmaceutical company headquartered in Nanjing, Jiangsu, China, founded in 2023 as a subsidiary of Simcere Pharmaceutical Group Limited. With 50–100 employees, it conducts research, development, manufacturing, and commercialization of cancer therapeutics. The company has advanced multiple programs through partnerships, including an antibody drug conjugate expanded into United States trials in 2025.

Simcere Zaiming

Verified Nov 2026

AT A GLANCE

Founded

2023

Headquarters

China flag

Nanjing, Jiangsu

Employees

50-100

Ownership

Simcere Zaiming at a glance

Employees

50-100

Founded

2023

Headquarters

Nanjing, Jiangsu

Industries

Automotive

Electric Vehicles

Medical

Overview

Simcere Zaiming is an oncology-focused biopharmaceutical company headquartered in Nanjing, Jiangsu, China, founded in 2023 as a subsidiary of Simcere Pharmaceutical Group Limited. With 50–100 employees, it conducts research, development, manufacturing, and commercialization of cancer therapeutics. The company has advanced multiple programs through partnerships, including an antibody drug conjugate expanded into United States trials in 2025.

At a glance

Attribute

Detail

Founded

2023

Headquarters

Nanjing, Jiangsu

Employees

50-100

What Simcere Zaiming makes

The company develops oncology drugs including COSELA®, Endostar®, and Envafolimab®, alongside early-stage programs such as antibody drug conjugates and dual-target antibody treatments for inflammatory bowel disease.

Latest developments

Company details

Simcere Zaiming operates a complete value chain encompassing internal R&D, manufacturing, and commercialization, and pursues strategic global partnerships to expand its therapeutic portfolio and market reach. Simcere Zaiming was founded in 2023, has an estimated 50-100 employees, and is headquartered in Nanjing, Jiangsu.

Frequently asked questions

What does Simcere Zaiming do?

Simcere Zaiming is an oncology-focused biopharmaceutical company headquartered in Nanjing, Jiangsu, China, founded in 2023 as a subsidiary of Simcere Pharmaceutical Group Limited. With 50–100 employees, it conducts research, development, manufacturing, and commercialization of cancer therapeutics. The company has advanced multiple programs through partnerships, including an antibody drug conjugate expanded into United States trials in 2025.

Where is Simcere Zaiming headquartered?

Simcere Zaiming is headquartered in Nanjing, Jiangsu.

When was Simcere Zaiming founded?

Simcere Zaiming was founded in 2023.

How big is Simcere Zaiming?

Simcere Zaiming has an estimated 50-100 employees.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Nanjing, Jiangsu (HQ)Headquarters · Jiangsu, China
Nanjing, Jiangsu (HQ)Nanjing, Jiangsu, ChinaHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.